Allstate Corp Y M Abs Therapeutics, Inc. Transaction History

Allstate Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$15.51 - $29.31 $145,700 - $275,338	-9,394 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$25.45 - $37.64 $62,479 - $92,406	2,455 Added 35.38%	9,394 $318,000
Q1 2021 May 14, 2021	BUY	$29.16 - $51.96 $29,509 - $52,583	1,012 Added 17.07%	6,939 $210,000
Q3 2020 Nov 13, 2020	SELL	$35.13 - $43.62 $4,215 - $5,234	-120 Reduced 1.98%	5,927 $228,000
Q2 2020 Aug 13, 2020	BUY	$23.66 - $49.53 $143,072 - $299,507	6,047 New	6,047 $261,000

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $254M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.